Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed 41 (TEX41) is a long non-coding RNA (lncRNA), also classified as an enhancer RNA (eRNA), encoded on chromosome 2 and not translated into a functional protein[1][4][5]. It is involved in the regulation of mRNA splicing, processing of ribosomal RNA, and ribosome assembly[1]. In cancer, elevated TEX41 expression is associated with poor prognosis and leads to increased cell proliferation and migration, as observed in melanoma, renal cell carcinoma, and squamous cell carcinoma[2][3]. TEX41 exerts regulatory effects through several molecular mechanisms, including functioning as a competing endogenous RNA (sequestering miRNAs such as miR-153-3p) and modulating chromatin and transcription factor activity[2][3]. These functions may influence cancer progression by affecting pathways like transcriptional misregulation, melanogenesis, and immune cell infiltration in the tumor microenvironment[2][3]. No approved drugs directly target TEX41, but its emerging roles in oncogenesis and immune response make it a subject of research as a potential biomarker and therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed 41 (non-protein coding) (TEX41).